Cerebrospinal fluid and serum uric acid levels in patients with multiple sclerosis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Erschienen in
-
In: Clinical Chemistry and Laboratory Medicine, Band 47, Ausgabe 7, Seite 848-853, 2009
- Ereignis
-
Veröffentlichung
- (wo)
-
Berlin
- (wer)
-
Humboldt-Universität zu Berlin
- (wann)
-
2009
- Urheber
-
Dujmovic, Irena
Pekmezovic, Tatjana
Obrenovic, Radmila
Nikolić, Aleksandra
Spasic, Mihailo
Stojkovic, Marija Mostarica
Drulovic, Jelena
- DOI
-
10.18452/12468
- URN
-
urn:nbn:de:kobv:11-100159163
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:52 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Dujmovic, Irena
- Pekmezovic, Tatjana
- Obrenovic, Radmila
- Nikolić, Aleksandra
- Spasic, Mihailo
- Stojkovic, Marija Mostarica
- Drulovic, Jelena
- Humboldt-Universität zu Berlin
Entstanden
- 2009
Ähnliche Objekte (12)
Cerebrospinal fluid analysis in multiple sclerosis
Cerebrospinal fluid cells immune landscape in multiple sclerosis
Primary progressive multiple sclerosis (PPMS) – cerebrospinal fluid (CSF) profile
Monoaminergic and Kynurenergic Characterization of Frontotemporal Dementia and Amyotrophic Lateral Sclerosis in Cerebrospinal Fluid and Serum
Bound and Free Light Chains in Subacute Sclerosing Panencephalitis and Multiple Sclerosis Serum and Cerebrospinal Fluid
Adiponectin levels in the serum and cerebrospinal fluid of amyotrophic lateral sclerosis patients: possible influence on neuroinflammation?
Diagnostic Cerebrospinal Fluid Biomarker in Early and Late Onset Multiple Sclerosis
Cerebrospinal fluid research
Cerebrospinal fluid rhinorrhea
Serum uric acid levels in patients with amyotrophic lateral sclerosis: a meta-analysis
Increased cerebrospinal fluid adenosine 5'-triphosphate in patients with amyotrophic lateral sclerosis
High serum uric acid levels are protective against cognitive impairment in amyotrophic lateral sclerosis
Cerebrospinal fluid analysis in multiple sclerosis
Cerebrospinal fluid cells immune landscape in multiple sclerosis
Primary progressive multiple sclerosis (PPMS) – cerebrospinal fluid (CSF) profile
Monoaminergic and Kynurenergic Characterization of Frontotemporal Dementia and Amyotrophic Lateral Sclerosis in Cerebrospinal Fluid and Serum
Bound and Free Light Chains in Subacute Sclerosing Panencephalitis and Multiple Sclerosis Serum and Cerebrospinal Fluid
Adiponectin levels in the serum and cerebrospinal fluid of amyotrophic lateral sclerosis patients: possible influence on neuroinflammation?
Diagnostic Cerebrospinal Fluid Biomarker in Early and Late Onset Multiple Sclerosis
Cerebrospinal fluid research
Cerebrospinal fluid rhinorrhea
Serum uric acid levels in patients with amyotrophic lateral sclerosis: a meta-analysis
Increased cerebrospinal fluid adenosine 5'-triphosphate in patients with amyotrophic lateral sclerosis
High serum uric acid levels are protective against cognitive impairment in amyotrophic lateral sclerosis
Cerebrospinal fluid analysis in multiple sclerosis
Cerebrospinal fluid cells immune landscape in multiple sclerosis
Primary progressive multiple sclerosis (PPMS) – cerebrospinal fluid (CSF) profile
Monoaminergic and Kynurenergic Characterization of Frontotemporal Dementia and Amyotrophic Lateral Sclerosis in Cerebrospinal Fluid and Serum
Bound and Free Light Chains in Subacute Sclerosing Panencephalitis and Multiple Sclerosis Serum and Cerebrospinal Fluid
Adiponectin levels in the serum and cerebrospinal fluid of amyotrophic lateral sclerosis patients: possible influence on neuroinflammation?
Diagnostic Cerebrospinal Fluid Biomarker in Early and Late Onset Multiple Sclerosis
Cerebrospinal fluid research
Cerebrospinal fluid rhinorrhea
Serum uric acid levels in patients with amyotrophic lateral sclerosis: a meta-analysis
Increased cerebrospinal fluid adenosine 5'-triphosphate in patients with amyotrophic lateral sclerosis